Thymic carcinoid in association with MEN syndromes

M. A. Zeiger, S. E. Swartz, D. C. Macgillivray, I. Linnoila, M. Shakir

Research output: Contribution to journalArticle

Abstract

Although carcinoid tumors in association with multiple endocrine neoplasia syndrome (MEN) has been well described, thymic carcinoid in association with MEN is extremely rare (only 23 cases in the world literature). A patient with thymic carcinoid and MEN-I was treated with surgical resection and postoperative radiation therapy, which was later followed by subtotal parathyroidectomy for hyperparathyroidism. Four years later, a symptomatic recurrence of his thymic carcinoid was resected from below his right clavicle. Six years after his original operation, the patient came to the hospital with pancreatitis, and a 5 cm, distal, pancreatic metastasis was resected. He now has symptomatic paraspinal and pleural metastases and is receiving somatostatin. Review of the world's literature shows that the majority of patients with thymic carcinoid and MEN-I are men with an average age of 37 years. Their clinical course is indolent, and surgery represents the only means of cure. Adjuvant chemotherapy and radiation therapy confer no survival advantage. The surgical decision making involved in treating a patient with thymic carcinoid and hyperparathyroidism associated with MEN is also discussed.

Original languageEnglish (US)
Pages (from-to)430-434
Number of pages5
JournalAmerican Surgeon
Volume58
Issue number7
StatePublished - 1992
Externally publishedYes

Fingerprint

Multiple Endocrine Neoplasia
Carcinoid Tumor
Hyperparathyroidism
Radiotherapy
Neoplasm Metastasis
Parathyroidectomy
Clavicle
Adjuvant Chemotherapy
Somatostatin
Pancreatitis
Decision Making
Recurrence
Survival

ASJC Scopus subject areas

  • Surgery

Cite this

Zeiger, M. A., Swartz, S. E., Macgillivray, D. C., Linnoila, I., & Shakir, M. (1992). Thymic carcinoid in association with MEN syndromes. American Surgeon, 58(7), 430-434.

Thymic carcinoid in association with MEN syndromes. / Zeiger, M. A.; Swartz, S. E.; Macgillivray, D. C.; Linnoila, I.; Shakir, M.

In: American Surgeon, Vol. 58, No. 7, 1992, p. 430-434.

Research output: Contribution to journalArticle

Zeiger, MA, Swartz, SE, Macgillivray, DC, Linnoila, I & Shakir, M 1992, 'Thymic carcinoid in association with MEN syndromes', American Surgeon, vol. 58, no. 7, pp. 430-434.
Zeiger MA, Swartz SE, Macgillivray DC, Linnoila I, Shakir M. Thymic carcinoid in association with MEN syndromes. American Surgeon. 1992;58(7):430-434.
Zeiger, M. A. ; Swartz, S. E. ; Macgillivray, D. C. ; Linnoila, I. ; Shakir, M. / Thymic carcinoid in association with MEN syndromes. In: American Surgeon. 1992 ; Vol. 58, No. 7. pp. 430-434.
@article{70fbaacc50134ce18384f875181f21fb,
title = "Thymic carcinoid in association with MEN syndromes",
abstract = "Although carcinoid tumors in association with multiple endocrine neoplasia syndrome (MEN) has been well described, thymic carcinoid in association with MEN is extremely rare (only 23 cases in the world literature). A patient with thymic carcinoid and MEN-I was treated with surgical resection and postoperative radiation therapy, which was later followed by subtotal parathyroidectomy for hyperparathyroidism. Four years later, a symptomatic recurrence of his thymic carcinoid was resected from below his right clavicle. Six years after his original operation, the patient came to the hospital with pancreatitis, and a 5 cm, distal, pancreatic metastasis was resected. He now has symptomatic paraspinal and pleural metastases and is receiving somatostatin. Review of the world's literature shows that the majority of patients with thymic carcinoid and MEN-I are men with an average age of 37 years. Their clinical course is indolent, and surgery represents the only means of cure. Adjuvant chemotherapy and radiation therapy confer no survival advantage. The surgical decision making involved in treating a patient with thymic carcinoid and hyperparathyroidism associated with MEN is also discussed.",
author = "Zeiger, {M. A.} and Swartz, {S. E.} and Macgillivray, {D. C.} and I. Linnoila and M. Shakir",
year = "1992",
language = "English (US)",
volume = "58",
pages = "430--434",
journal = "American Surgeon",
issn = "0003-1348",
publisher = "Southeastern Surgical Congress",
number = "7",

}

TY - JOUR

T1 - Thymic carcinoid in association with MEN syndromes

AU - Zeiger, M. A.

AU - Swartz, S. E.

AU - Macgillivray, D. C.

AU - Linnoila, I.

AU - Shakir, M.

PY - 1992

Y1 - 1992

N2 - Although carcinoid tumors in association with multiple endocrine neoplasia syndrome (MEN) has been well described, thymic carcinoid in association with MEN is extremely rare (only 23 cases in the world literature). A patient with thymic carcinoid and MEN-I was treated with surgical resection and postoperative radiation therapy, which was later followed by subtotal parathyroidectomy for hyperparathyroidism. Four years later, a symptomatic recurrence of his thymic carcinoid was resected from below his right clavicle. Six years after his original operation, the patient came to the hospital with pancreatitis, and a 5 cm, distal, pancreatic metastasis was resected. He now has symptomatic paraspinal and pleural metastases and is receiving somatostatin. Review of the world's literature shows that the majority of patients with thymic carcinoid and MEN-I are men with an average age of 37 years. Their clinical course is indolent, and surgery represents the only means of cure. Adjuvant chemotherapy and radiation therapy confer no survival advantage. The surgical decision making involved in treating a patient with thymic carcinoid and hyperparathyroidism associated with MEN is also discussed.

AB - Although carcinoid tumors in association with multiple endocrine neoplasia syndrome (MEN) has been well described, thymic carcinoid in association with MEN is extremely rare (only 23 cases in the world literature). A patient with thymic carcinoid and MEN-I was treated with surgical resection and postoperative radiation therapy, which was later followed by subtotal parathyroidectomy for hyperparathyroidism. Four years later, a symptomatic recurrence of his thymic carcinoid was resected from below his right clavicle. Six years after his original operation, the patient came to the hospital with pancreatitis, and a 5 cm, distal, pancreatic metastasis was resected. He now has symptomatic paraspinal and pleural metastases and is receiving somatostatin. Review of the world's literature shows that the majority of patients with thymic carcinoid and MEN-I are men with an average age of 37 years. Their clinical course is indolent, and surgery represents the only means of cure. Adjuvant chemotherapy and radiation therapy confer no survival advantage. The surgical decision making involved in treating a patient with thymic carcinoid and hyperparathyroidism associated with MEN is also discussed.

UR - http://www.scopus.com/inward/record.url?scp=0026632678&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026632678&partnerID=8YFLogxK

M3 - Article

C2 - 1352092

AN - SCOPUS:0026632678

VL - 58

SP - 430

EP - 434

JO - American Surgeon

JF - American Surgeon

SN - 0003-1348

IS - 7

ER -